Granata Bio
Boston, United States · Founded 2021 · $29.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- granata.bio
- Total Funding
- $29.0M
- Last Round
- $15.0M Extension RoundJan 2025
- Rounds
- 2
About
Granata Bio is a clinical-stage biopharmaceutical company focused on reproductive health, identifying and developing fertility treatments to expand therapeutic choices and improve access for patients. Founded in 2018 and based in Duxbury, Massachusetts, the company is advancing a pivotal Phase III study of a novel gonadotropin for assisted reproductive technology.
Summary
Granata Bio is a company based in Boston, United States, founded in 2021. It has raised $29.0M in total across 2 rounds, most recently a $15.0M Extension Round round in Jan 2025. Investors include GV, Gedeon Richter and CooperSurgical.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
